AL-Saeedi et al., 2018 - Google Patents
Bacteriocin from Streptococcus salivarius optimized statistically by response surface methodology active against different clinical oral pathogenic StreptococciAL-Saeedi et al., 2018
View PDF- Document ID
- 197509432169723760
- Author
- AL-Saeedi B
- Luti K
- Publication year
- Publication venue
- Iraqi Journal of Science
External Links
Snippet
The aim of the present work was to study the possibility of producing an effective bacteriocin from bacteria naturally exists in the mouth. Streptococcus salivarius KA101 was selected among 120 oral isolates collected from healthy people based on its ability to produce an …
- 101700017503 BACT 0 title abstract description 105
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/96—Cosmetic or similar toilet preparations characterised by the composition containing material, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetic or similar toilet preparations characterised by the composition containing material, or derivatives thereof of undetermined constitution from micro-organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases Endopeptidases (3.4.21-3.4.25) derived from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—PROCESSES USING MICRO-ORGANISMS
- C12R1/00—Processes using micro-organisms
- C12R1/01—Processes using micro-organisms using bacteria or actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Garrote et al. | Inhibitory power of kefir: the role of organic acids | |
Wannun et al. | Purification, characterization, and optimum conditions of fermencin SD11, a bacteriocin produced by human orally Lactobacillus fermentum SD11 | |
Hasslöf et al. | Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli-an in vitro study | |
EP1816190B1 (en) | New lactic bacteria useful as probiotics | |
Jäsberg et al. | Bifidobacteria inhibit the growth of Porphyromonas gingivalis but not of Streptococcus mutans in an in vitro biofilm model | |
Galindo-Cuspinera et al. | Antimicrobial properties of commercial annatto extracts against selected pathogenic, lactic acid, and spoilage microorganisms | |
US20040038379A1 (en) | Probiotic strains from Lactobacillus salivarius and antimicrobial agents obtained therefrom | |
Mahdi et al. | Antibacterial immunomodulatory and antibiofilm triple effect of Salivaricin LHM against Pseudomonas aeruginosa urinary tract infection model | |
Sudhir et al. | Assessment of the effect of probiotic curd consumption on salivary pH and streptococcus mutans counts | |
AL-Saeedi et al. | Bacteriocin from Streptococcus salivarius optimized statistically by response surface methodology active against different clinical oral pathogenic Streptococci | |
Tavakoli et al. | Characterization of probiotic abilities of Lactobacilli isolated from Iranian Koozeh traditional cheese | |
JP2007502858A (en) | At least two lactic acid bacteria that can form colonies in the gastrointestinal tract of humans and animals and have at least two advantages selected from intestinal viability, intestinal binding, infection protection and fiber fermentability Probiotic compositions containing strains | |
Lin et al. | Inhibitory effect of Lactobacillus paracasei subsp. paracasei NTU 101 on rat dental caries | |
Azizian et al. | Genetic diversity of Lactobacillus spp. isolates from oral cavity and their probiotic and antimicrobial properties | |
Noori et al. | Growth optimization of Lactobacillus plantarum T5jq301796. 1, an Iranian indigenous probiotic in lab scale fermenter | |
Mandal et al. | Purification and characterization of pediocin produced by Pediococcus acidilactici NCIM 2292 | |
Diani et al. | The interactions between esp, fsr, gelE genes and biofilm formation and pfge analysis of clinical Enterococcus faecium strains | |
Cleghorn et al. | The effect of pH on the sensitivity of species of Lactobacillus to chlorhexidine and the antibiotics minocycline and spiramycin | |
Goudarzi et al. | Evaluation of Antimicrobial Activity of Probiotic Lactobacillus Strains against Growth and Urease Activity of Proteus spp. | |
Szemes et al. | On the origin of reactive oxygen species and antioxidative mechanisms in Enterococcus faecalis | |
KR101712981B1 (en) | Manufacturing method of probiotics powder containing goat milk | |
Hasan et al. | Isolation, identification and evaluation of lactic acid bacteria as antibacterial activity | |
Figueiredo et al. | Probiotics in human health | |
Deo et al. | Evaluation of salivary levels of Streptococcus mutans pre-and post-probiotics use | |
Batjargal | Probiotic properties of lactic acid bacteria isolated from Mongolian fermented mare’s milk |